ACUTE GRAFT-VERSUS-HOST DISEASE IN RECIPIENTS OF BONE-MARROW TRANSPLANTS FROM IDENTICAL TWIN DONORS

[1]  E. Reinherz,et al.  Aberrations of suppressor T cells in human graft-versus-host disease. , 1979, The New England journal of medicine.

[2]  D. Nelson,et al.  Virus specificity of human influenza virus-immune cytotoxic T cells. , 1979, Journal of immunology.

[3]  A. Meshorer,et al.  Syngeneic GvH induced in popliteal lymph nodes by spleen cells of old C57BL/6 mice. , 1978, Journal of immunology.

[4]  J. Sprent,et al.  Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow , 1978, The Journal of experimental medicine.

[5]  T. Diamantstein,et al.  Studies on induction and control of cell‐mediated autoimmunity I. Induction of “autoreactive” T Iymphocytes in mice by cyclophosphamide , 1978, European journal of immunology.

[6]  R. Parkman,et al.  The control of autoreactivity. I. Lack of autoreactivity in murine spleens is due to concomitant presence of suppressor and autocytotoxic lymphocytes. , 1978, Journal of immunology.

[7]  G. Shearer,et al.  Human cytotoxic response in vitro to trinitrophenyl-modified autologous cells. I. T cell recognition of TNP in association with widely shared antigens. , 1978, Journal of immunology.

[8]  R. Storb,et al.  Deposition of IgM and complement at the dermoepidermal junction in acute and chronic cutaneous graft-vs-host disease in man. , 1978, Journal of immunology.

[9]  J. Belli,et al.  Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation. , 1978, The New England journal of medicine.

[10]  L. Chess,et al.  Cell-mediated lympholysis of trinitrophenyl-derivatized autologous human cells: in vitro triggering by nonspecific signals. , 1978, Journal of Immunology.

[11]  A. Gratwohl,et al.  Scleroderma, Sjögren-like syndrome, and chronic graft-versus-host disease. , 1977, Annals of internal medicine.

[12]  R. Storb,et al.  Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival. , 1977, The Journal of clinical investigation.

[13]  P. Neiman,et al.  One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. , 1977, Blood.

[14]  D. L. Klein,et al.  HL-A-identical marrow transplants in aplastic anemia, acute leukemia, and lymphosarcoma employing cyclophosphamide. , 1976, Transplantation proceedings.

[15]  F. Rosen,et al.  Identification of a subpopulation of lymphocytes in human peripheral blood cytotoxic to autologous fibroblasts , 1976, The Journal of experimental medicine.

[16]  R. Storb,et al.  Direct and antibody-dependent cell-mediated cytotoxicity against HLA identical sibling lymphocytes. Correlation with marrow graft rejections. , 1976, Transplantation.

[17]  F. Rosen,et al.  DETECTION OF GENETICALLY DETERMINED HISTOCOMPATIBILITY ANTIGEN DIFFERENCES BETWEEN HL‐A IDENTICAL AND MLC NONREACTIVE SIBLINGS , 1976, Transplantation.

[18]  H. Weiss,et al.  Impaired interaction (adhesion-aggregation) of platelets with the subendothelium in storage-pool disease and after aspirin ingestion. A comparison with von Willebrand's disease. , 1975, The New England journal of medicine.

[19]  R Storb,et al.  Bone-marrow transplantation (first of two parts). , 1975, The New England journal of medicine.

[20]  W. Rosse,et al.  Quantitative determination of antibody in idiopathic thrombocytopenic purpura. Correlation of serum and platelet-bound antibody with clinical response. , 1975, The New England journal of medicine.

[21]  R. Storb,et al.  Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. , 1974, Transplantation proceedings.

[22]  P. Neiman,et al.  CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.

[23]  T. Stossel,et al.  Phagocytosis of antibody-coated platelets by human granulocytes. , 1974, The New England journal of medicine.

[24]  D. Nathan,et al.  Posthepatitic severe aplastic anemia--an indication for early bone marrow transplantation. , 1974, Blood.

[25]  P. Neiman,et al.  Allogeneic marrow grafting for treatment of aplastic anemia. , 1974, Blood.

[26]  E. Gelfand,et al.  Severe combined immunodeficiency and adenosine deaminase deficiency. , 1973, The New England journal of medicine.

[27]  R. Slavin,et al.  The graft versus host reaction in man after bone marrow transplantation: pathology, pathogenesis, clinical features, and implication. , 1973, Clinical immunology and immunopathology.

[28]  R. Graff,et al.  The Non‐H‐2 Histocompatibility Loci and Their Antigens , 1973, Transplantation reviews.

[29]  I. Cohen,et al.  AUTOSENSITIZATION IN VITRO , 1971, The Journal of experimental medicine.

[30]  C. Alper,et al.  Genetic polymorphism of the third component of human complement (C'3). , 1968, The Journal of clinical investigation.

[31]  P. Terasaki,et al.  Microdroplet Assay of Human Serum Cytotoxins , 1964, Nature.

[32]  K. Hirschhorn,et al.  Lymphocyte Interaction: A Potential Histocompatibility Test in vitro , 1964, Science.

[33]  F. Gardner,et al.  Survival of blood platelets labeled with chromium. , 1958, The Journal of clinical investigation.